Immune Responses in Otitis Prone Children
易患中耳炎的儿童的免疫反应
基本信息
- 批准号:8823637
- 负责人:
- 金额:$ 64.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdherenceAdoptedAntibiotic TherapyAntibodiesAntibody ResponseAntigen-Presenting CellsAntigensAutomobile DrivingB-LymphocytesBacteriaCD4 Positive T LymphocytesCell physiologyCensusesChildChildhoodClinical ResearchCommunicable DiseasesCost SavingsDataDefectDevelopment PlansDiagnosisDiseaseDisease ProgressionDropsEpithelialEpithelial CellsFunctional disorderFundingFutureGenerationsHaemophilus VaccinesHearingHelper-Inducer T-LymphocyteImmuneImmune responseImmunityImmunologic Deficiency SyndromesImmunologicsInfectionInflammationInflammatoryInflammatory ResponseKnowledgeLanguage DevelopmentLeadMediator of activation proteinMethodologyMorbidity - disease rateMucosal Immune ResponsesMucosal ImmunityMucous MembraneNatural ImmunityNeonatalNontypable Haemophilus influenzaNoseOtitisOtitis MediaPathogenesisPathogenicityPathway interactionsPhenotypePopulationPreparationProteinsPublicationsRecurrenceResearchResistanceRoleSerumShapesSpeech DevelopmentStreptococcus pneumoniaeT memory cellT-LymphocyteToll-like receptorsTympanostomyUp-RegulationVaccinesViralViral Tumor AntigensVirusVirus Diseasesadaptive immunityagedco-infectioncytokinedefined contributiondesignhearing impairmentimmunogenicitymeetingsmiddle earpathogenprospectivereceptorrepositoryrespiratoryresponsesample collectiontime intervaltraffickingtranslational studyvaccine candidatevaccine development
项目摘要
DESCRIPTION (provided by applicant): Acute Otitis Media (AOM) is the most common infectious disease among children. During AOM, children typically have diminished hearing and this can lead to temporary delayed speech and language development and possibly permanent hearing loss. This project seeks support to continue our prospective, longitudinal clinical and translational studies of AOM (RO1 DC 08671) with a specific focus on defining the adaptive and innate immune response deficits among otitis prone (OP) children to infections caused by nontypeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae (Spn). To better understand NTHi and Spn pathogenesis and assist in vaccine development we plan to (1) identify specific adaptive immune deficits in OP children; (2) determine independent contributions of mucosal immunity in OP children; (3) understand the role of innate responses to co-infection of respiratory bacteria and viruses; and (4) define the role of differences in the nasopharyngeal (NP) inflammatory response in shaping the mucosal microenvironment to allow for NTHi/ Spn colonization and then infection. Therefore, we will investigate: 1. The mechanisms causing a diminished capacity to generate adaptive immune responses to NTHi and Spn following NP colonization and AOM in OP versus non-OP (NOP) children. We will define mechanisms causing poor T-cell function with respect to immune maturity and examine the capacity to generate memory T-cells, compare the generation and activity of NTHi/Spn specific B-cells, define key intrinsic differences of antigen-presenting cell function and evaluate mucosal immune responses. 2. The contributions of innate immunity that alters the NP microenvironment to favor NTHi and Spn colonization during concurrent viral infections to aid the pathogenesis of AOM. We will determine the level of NP and middle ear up-regulation of NTHi/Spn epithelial adherence receptors during antecedent respiratory viral infections; define the role of pro-inflammatory cytokine mediators induced by respiratory viral infections in modifying resistance to NTHi/Spn colonization; and characterize expression of toll like receptors (TLR) as mediators of innate and adaptive immune response clearance of NTHi/Spn colonization. During our current funding time interval, we have re-defined the OP child phenotype thereby providing new clarity and direction in the study of these children. Further understanding immune defects in OP children, will point the way to rational design of future candidate vaccines. Second, we will establish the key mediators of "controlled" inflammation in the NP during colonization that promote an effective immune response compared to pathological "uncontrolled" inflammation that allows disease progression. From that knowledge we can seek to modulate or silence those innate immune response pathways that facilitate disease progression while preserving the necessary innate responses that facilitate protective immunogenicity.
描述(由申请人提供):急性中耳炎(AOM)是儿童中最常见的传染病。在AOM期间,儿童通常会减少听力,这可能导致暂时延迟的语音和语言发展以及可能永久性听力损失。该项目寻求支持,以继续我们对AOM的前瞻性,纵向临床和翻译研究(RO1 DC 08671),其特定重点是定义容易发生的适应性和先天免疫反应不足(OP)儿童(OP)儿童对由不可能的嗜血性嗜血杆菌(NTHI)和prepteptocccus pnecoccus pnee(NTHI)和pnecoccus pnee(NTHI)引起的感染引起的感染。为了更好地了解NTHI和SPN发病机理并有助于疫苗开发,我们计划(1)确定OP儿童的特定适应性免疫缺陷; (2)确定OP儿童中粘膜免疫的独立贡献; (3)了解对呼吸细菌和病毒共同感染的先天反应的作用; (4)定义差异在鼻咽(NP)炎症反应中的作用在塑造粘膜微环境中以允许NTHI/ SPN定植,然后再感染。因此,我们将研究:1。导致NP定植后对NTHI和SPN产生适应性免疫反应的能力降低的机制,而OP(NOP)儿童的AOM和AOM。我们将定义导致T细胞功能不良的免疫成熟度的机制,并检查产生记忆T细胞的能力,比较NTHI/SPN特异性B细胞的产生和活性,定义了抗原呈递细胞功能的关键内在差异并评估粘膜免疫反应。 2。在并发病毒感染期间,改变NP微环境的先天免疫力促进NP微环境有利于NTHI和SPN定植,以帮助AOM的发病机理。我们将确定在呼吸道病毒感染期间NTHI/SPN上皮依从性受体的NP和中耳上调的水平;定义呼吸道病毒感染诱导的促炎性细胞因子介质在改变对NTHI/SPN定殖的抗性中的作用;并将像受体(TLR)的表达表达为NTHI/SPN定植的先天和适应性免疫反应清除率的介体。在当前的资助时间间隔中,我们重新定义了OP子表型,从而在研究这些孩子的研究中提供了新的清晰度和方向。进一步了解OP儿童的免疫缺陷将为未来候选疫苗的合理设计指向道路。其次,我们将在定植期间建立NP中“受控”炎症的关键介质,与病理“不受控制”的炎症相比,促进了有效的免疫反应,从而允许疾病进展。从这些知识中,我们可以寻求调节或沉默那些促进疾病进展的先天免疫反应途径,同时保留促进保护性免疫原性的必要先天反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E PICHICHERO其他文献
MICHAEL E PICHICHERO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E PICHICHERO', 18)}}的其他基金
Clinical Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma
临床核心:IDEAL 影响疫苗反应、呼吸道传染病和哮喘的易感性
- 批准号:
10589805 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别:
Clinical Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma
临床核心:IDEAL 影响疫苗反应、呼吸道传染病和哮喘的易感性
- 批准号:
10435038 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别:
Immune biomarker discovery in children susceptible to recurrent otitis media
易患复发性中耳炎的儿童中免疫生物标志物的发现
- 批准号:
10452702 - 财政年份:2021
- 资助金额:
$ 64.28万 - 项目类别:
Immune biomarker discovery in children susceptible to recurrent otitis media
易患复发性中耳炎的儿童中免疫生物标志物的发现
- 批准号:
10286384 - 财政年份:2021
- 资助金额:
$ 64.28万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:72272131
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:32100850
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 64.28万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别:
A novel psychological-behavioral intervention to promote physical activity after acute coronary syndrome
一种促进急性冠脉综合征后身体活动的新型心理行为干预措施
- 批准号:
10448080 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别:
Development of a patient-provider decision aid for HIV post-exposure prophylaxis
开发艾滋病毒暴露后预防的患者-提供者决策辅助工具
- 批准号:
10836150 - 财政年份:2022
- 资助金额:
$ 64.28万 - 项目类别: